Janus Henderson Group
HUMA icon

Janus Henderson Group’s Humacyte HUMA Stock Holding History

Janus Henderson Group’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-36,900
Closed -$72.3K – 2451
2025
Q1 		$72.3K Hold
36,900
– – ﹤0.01% 2474
2024
Q4 		$186K Hold
36,900
– – ﹤0.01% 2446
2024
Q3 		$201K Buy
+36,900
New +$243K ﹤0.01% 2428
2023
Q1 		– Sell
-13,200
Closed -$27.7K – 2700
2022
Q4 		$27.7K Sell
13,200
-13,836
-51% -$42K ﹤0.01% 2445
2022
Q3 		$88K Buy
27,036
+13,224
+96% +$50.7K ﹤0.01% 2490
2022
Q2 		$44K Buy
13,812
+302
+2% +$1.68K ﹤0.01% 2561
2022
Q1 		$95K Sell
13,510
-3
-0% -$17 ﹤0.01% 2569
2021
Q4 		$98K Buy
+13,513
New +$134K ﹤0.01% 2504

Other funds holding HUMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Janus Henderson Group's HUMA Position: Q2 2025 in Review

Janus Henderson Group sold out of Humacyte (HUMA) in Q2 2025, closing a stake of 36,900 shares — an estimated $72.3K sold.

Janus Henderson Group first reported a position in HUMA in Q4 2021 and held it in 8 quarters. The position peaked at $201K in Q3 2024. 156 funds tracked by Wall St. Rank hold HUMA as of Q2 2025.

  • Janus Henderson Group reported no remaining Humacyte position as of Q2 2025 after selling out during the quarter.
  • Janus Henderson Group sold 36,900 Humacyte shares in Q2 2025, an estimated $72.3K.
  • Janus Henderson Group first reported a position in Humacyte in Q4 2021 and held it in 8 quarters.
  • Janus Henderson Group's Humacyte position peaked at $201K in Q3 2024.
  • 156 funds tracked by Wall St. Rank held Humacyte as of Q2 2025.

Based on Janus Henderson Group's 13F filing for Q2 2025, filed 14 Aug 2025.